76 related articles for article (PubMed ID: 1036612)
1. [Neuroendocrine aspects of Parkinson's disease. Therapeutic/effect of a prolactin inhibitor].
Agnoli A; Casacchia M; Carolei A; Meco G; Zamponi A; Ruggieri S
Minerva Med; 1976 Nov; 67(53):. PubMed ID: 1036612
[TBL] [Abstract][Full Text] [Related]
2. Treatment of parkinson's disease with bromocriptine.
Lieberman A; Kupersmith M; Estey E; Goldstein M
N Engl J Med; 1976 Dec; 295(25):1400-4. PubMed ID: 989885
[TBL] [Abstract][Full Text] [Related]
3. Treatment of fibrocystic disease of the breast with a prolactin inhibitor: 2-Br-alpha-ergocryptine (CB-154).
Martin-Comin J; Pujol-Amat P; Cararach V; Davi E; Robyn C
Obstet Gynecol; 1976 Dec; 48(6):703-6. PubMed ID: 1036613
[TBL] [Abstract][Full Text] [Related]
4. [CB 154 in the treatment of Parkinson's disease. Results in combination with L-dopa and decarboxylase inhibitor].
Meco G; Casacchia M; Zamponi A; Agnoli A
Acta Neurol (Napoli); 1976; 31(4):479-48. PubMed ID: 1037427
[No Abstract] [Full Text] [Related]
5. [Treatment of Parkinson's disease with bromocriptine].
Castaigne P; Laplane D; Bousser MG; Bories F
Nouv Presse Med; 1976 Apr; 6(17):1482. PubMed ID: 1037400
[No Abstract] [Full Text] [Related]
6. [Antiprolactin therapy in the treatment of benign lesions of the breast. Comparison of bromocryptine and methergoline].
Mussa A; Sandrucci S; Dogliotti L
Minerva Med; 1979 Nov; 70(51):3493-8. PubMed ID: 522987
[TBL] [Abstract][Full Text] [Related]
7. Dopamine agonists in the treatment of Parkinson's disease.
Rinne UK
Adv Neurol; 1983; 37():141-50. PubMed ID: 6305175
[TBL] [Abstract][Full Text] [Related]
8. [Oral lisuride in Parkinson's disease].
Obeso JA; Luquin MR; MartÃnez Lage JM
Med Clin (Barc); 1985 Sep; 85(8):307-12. PubMed ID: 4068822
[No Abstract] [Full Text] [Related]
9. [Bromocriptine and Parkinson's disease: initial results].
Petit H; Destee A
Lille Med; 1977; 22(6):362-5. PubMed ID: 578286
[No Abstract] [Full Text] [Related]
10. CQP 201-403 in Parkinson's disease: an open-label pilot study.
Pfeiffer RF; Herrera LH; Glaeske CS; Hofman RE
Mov Disord; 1989; 4(3):278-81. PubMed ID: 2571083
[TBL] [Abstract][Full Text] [Related]
11. Bromocriptine: problems with low-dose de novo therapy in Parkinson's disease.
Grimes JD; Delgado MR
Clin Neuropharmacol; 1985; 8(1):73-7. PubMed ID: 3978651
[TBL] [Abstract][Full Text] [Related]
12. Bromocriptine in Parkinson disease.
Lieberman AN; Goldstein M
Pharmacol Rev; 1985 Jun; 37(2):217-27. PubMed ID: 3901046
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's disease.
Lieberman AN; Neophytides A; Leibowitz M; Gopinathan G; Pact V; Walker R; Goodgold A; Goldstein M
Adv Neurol; 1983; 37():95-108. PubMed ID: 6858782
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Parkinson's disease with bromocriptine.
Jotkowitz S
N Engl J Med; 1977 Sep; 297(9):508-9. PubMed ID: 578000
[No Abstract] [Full Text] [Related]
15. Effect of subcutaneous apomorphine on tremor in idiopathic Parkinson's disease.
Hellmann MA; Sabach T; Melamed E; Djaldetti R
Biomed Pharmacother; 2008; 62(4):250-2. PubMed ID: 17967525
[TBL] [Abstract][Full Text] [Related]
16. [Letter: Efficacy of bromocriptine in 2 cases of levodopa-resistant parkinsonism].
Kissel P; Andre JM; Jacquier A
Nouv Presse Med; 1976 Jan; 5(4):210. PubMed ID: 1264671
[No Abstract] [Full Text] [Related]
17. Low-dose bromocriptine in the early phases of Parkinson's disease.
Tolosa E; Blesa R; Bayes A; Forcadell F
Clin Neuropharmacol; 1987 Apr; 10(2):168-74. PubMed ID: 3332610
[TBL] [Abstract][Full Text] [Related]
18. Changes in pituitary hormones serum levels in bromocryptine-treated parkinsonian patients.
Polleri A; Carolei A; Rolandi E; Masturzo P; Meco G; Agnoli A
Neuropsychobiology; 1977; 3(1):42-8. PubMed ID: 578293
[TBL] [Abstract][Full Text] [Related]
19. Sustained bromocriptine therapy in 50 previously untreated patients with Parkinson's disease.
Stern GM; Lees AJ
Adv Neurol; 1983; 37():17-21. PubMed ID: 6858771
[TBL] [Abstract][Full Text] [Related]
20. Dopamine agonists as primary treatment in Parkinson's disease.
Rinne UK
Adv Neurol; 1987; 45():519-23. PubMed ID: 3103394
[No Abstract] [Full Text] [Related]
[Next] [New Search]
